YONGBING PU: Open Payments
NPI 1083832661 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 50 payments from 16 companies in 2025. Trend: 2023 $866 · 2024 $1,446 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $166 |
| Stryker Corporation | 1 | $155 |
| Alkermes, Inc. | 5 | $100 |
| Neurocrine BioSciences, Inc. | 4 | $96 |
| Teva Pharmaceuticals USA, Inc. | 5 | $84 |
| Supernus Pharmaceuticals, Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| ABBVIE INC. | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 1 | $66 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
Products named: COBENFY, FLOWTRIEVER CATHETER, S, ARISTADA, INGREZZA, Qelbree, REXULTI, VRAYLAR, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
